Skip to content

Somru Adapts Platform for COVID-19

Charlottetown-based Somru BioScience Inc. is adapting its antibody platform to assist in developing therapeutic and diagnostic solutions for COVID-19 and other infectious diseases.

The company has been developing a range of products centred around antibody technology for research, diagnostic and clinical applications. The products have been mainly used so far in research, with clients in 27 countries.

Read full story on Entrevestor

Scroll To Top